EDGAR Filing Documents for 0001104659-03-010399

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001104659-03-010399

Filing Date

2003-05-15

Accepted

2003-05-15 16:57:14

Documents

Period of Report

2003-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	j9805_10q.htm	10-Q	478241
3	EX-3.1	j9805_ex3d1.htm	EX-3.1	168183
4	EX-3.2	j9805_ex3d2.htm	EX-3.2	68065
5	EX-10.34	j9805_ex10d34.htm	EX-10.34	23845
6	EX-10.35	j9805_ex10d35.htm	EX-10.35	30497
7	EX-10.36	j9805_ex10d36.htm	EX-10.36	63154
8	EX-10.37	j9805_ex10d37.htm	EX-10.37	59344
9	EX-10.38	j9805_ex10d38.htm	EX-10.38	58335
10	EX-10.39	j9805_ex10d39.htm	EX-10.39	103763
11	EX-99.1	j9805_ex99d1.htm	EX-99.1	5800
12	EX-99.2	j9805_ex99d2.htm	EX-99.2	5661
13	J9805EX10D39IMAGE001.GIF	j9805ex10d39image001.gif	GRAPHIC	204
	Complete submission text file	0001104659-03-010399.txt		1067742

Mailing Address

Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200

TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)